<DOC>
	<DOCNO>NCT01193660</DOCNO>
	<brief_summary>This randomize control study aim determine efficacy umbilical cord blood erythropoietin combination therapy child cerebral palsy .</brief_summary>
	<brief_title>Allogenic Umbilical Cord Blood Erythropoietin Combination Therapy Cerebral Palsy</brief_title>
	<detailed_description>Cerebral palsy disorder movement posture result nonprogressive lesion injury immature brain . It lead cause childhood onset disability one 's life . Umbilical cord blood ( UCB ) suggest therapeutic method cerebral palsy result animal study . Stem cell include UCB expect exert therapeutic efficacy functional recovery . It also suggest erythropoietin useful repair neurological injury brain . The main mechanism erythropoietin suppose neuroprotection neurogenesis would reinforce effect stem cell well . Although autologous umbilical cord would safe , child problem birth seldom autologous umbilical cord blood . Allogenic umbilical cord blood might useful child effect approve .</detailed_description>
	<mesh_term>Paralysis</mesh_term>
	<mesh_term>Cerebral Palsy</mesh_term>
	<mesh_term>Epoetin Alfa</mesh_term>
	<criteria>Known cerebral palsy Willing comply study procedure High risk pneumonia renal function deterioration use immunosuppressant Presence know genetic disease Possibility drug hypersensitivity relate study remedy History previous cell therapy Poor cooperation guardian , include inactive attitude rehabilitation Intractable seizure disorder Autism</criteria>
	<gender>All</gender>
	<minimum_age>10 Months</minimum_age>
	<maximum_age>10 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>umbilical cord blood</keyword>
	<keyword>stem cell</keyword>
	<keyword>cerebral palsy</keyword>
</DOC>